Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

October 19, 2026 Listing Department, Listing Department, National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot C-1, Block G, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (E), Dalal Street, Mumbai - 400 051 Mumbai - 400 001 Symbol: MAXHEALTH Scrip Code: 543220 Sub.: Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir / Madam, In continuation to our earlier intimations dated September 19, 2026 and October 19, 2026, we wish to inform that, the members of the Company on October 19, 2026, through Postal Ballot by way of remote e-voting have, inter-alia, approved the following: Max Healthcare Institute Limited - Performance Linked Restricted Stock Unit Scheme 2026 and grant of Performance Linked Restricted Stock Units to the Eligible Employees of the Company Grant of Performance Linked Restricted Stock Units under the ‘Max Healthcare Institute Limited - Performance Linked Restricted Stock Unit Scheme 2026’ to the Eligible Employees of the Subsidiary Companies Alteration of the Main Objects Clause of the Memorandum of Association of the Company Details as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure. This disclosure will also be hosted on Company's website viz. www.maxhealthcare.in. Kindly take the same on record. Thanking you Yours truly, For Max Healthcare Institute Limited Dhiraj Aroraa EVP - Company Secretary and Compliance Officer Encl.: As above Annexure Details with respect to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 a. Max Healthcare Institute Limited - Performance Linked Restricted Stock Unit Scheme 2026 Particulars Details 1. Whether the scheme is in terms Yes of SEBI (SBEB) Regulations, 2021 2. Total number of shares covered The total number of Shares that may be issued and allotted pursuant to by these options the Exercise of Performance Linked Restricted Stock Unit (“PRSUs”) under Max Healthcare Institute Limited - Performance Linked Restricted Stock Unit Scheme 2026 (“MHIL PRSU Scheme 2026”) granted under the Scheme shall not exceed 73,50,000 equity shares of the Company of face value ₹10/- each, representing ~0.76% of the paid-up equity share capital of the Company as on August 13, 2026. 3. Pricing formula The Exercise Price of each PRSU shall be equal to the face value of one Equity Share of the Company prevailing on the Grant Date, which is presently ₹10/- per Equity Share. 4. Time within which options may Exercise Period shall commence on the respective Vesting Date and shall be exercised expire upon completion of three years from the date of such Vesting. 5. Brief details of significant terms The significant terms are as per the MHIL PRSU Scheme 2026 available on the Company’s website at www.maxhealthcare.in/employee-benefit- scheme-documents. Note: Since the MHIL PRSU Scheme 2026 has been approved by the Members of the Company, but no Options have been granted under the Scheme as on date, details such as: brief details of options granted, Options vested, Options exercised, Money realized by exercise of Options, Options lapsed, Total number of shares arising as a result of exercise of options, Variation of Terms of options, subsequent changes or cancellation or exercise of such Options, diluted earnings per share pursuant to issue of equity shares on exercise of options, etc. specified by the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are not applicable at this point of time. b. Alteration of the Main Objects Clause of the Memorandum of Association of the Company Particulars Details 1. Brief details of amendment in Amendment in Clause III. (A) titled ‘THE MAIN OBJECTS TO BE Memorandum of Association of the PURSUED BY THE COMPANY ON ITS INCORPORATION ARE’ of Company the Memorandum of Association of the Company by inserting the following sub-Clauses 7, 8 and 9 after the existing sub-Clause 6, subject to the approval of Registrar of Companies/ Ministry of Corporate Affairs: 7. To establish, promote, develop, own, acquire, run, manage and operate medical colleges, medical institutions, teaching institutions and other educational institutions for imparting undergraduate, postgraduate, doctoral and other medical, healthcare and allied health education and training, including education and training in medicine, nursing, pharmacy, physiotherapy, rehabilitation, allied health sciences, healthcare administration, hospital management and other related disciplines, including degree, diploma, fellowship and certification programmes, and to establish, develop and operate teaching hospitals, clinical and other facilities and programmes in connection therewith, and to undertake research, skill development, professional training and certification in such fields, subject to applicable laws and the approvals, permissions, recognitions and accreditations of the competent authorities 8. To manufacture, formulate, process, develop, produce, prepare, package, market, distribute, sell, purchase, import, export, supply and otherwise deal in pharmaceuticals, pharmaceutical preparations, formulations, medicines, drugs, medical preparations, enzymes, pharmaceutical intermediates, injectables, radiopharmaceuticals, radioisotopes and other medical, healthcare and allied products, including Fluorodeoxyglucose (FDG) and other radiopharmaceuticals and radioisotopes produced, processed or used through cyclotron, proton and other particle accelerator facilities and technologies, and sanitary, surgical and other medical supplies, and to establish, acquire, install, operate and maintain cyclotron, proton and other particle accelerator facilities and related laboratories, equipment and infrastructure for the manufacture, production, processing, research, development and application of such products, and to undertake all research, development and other activities incidental or conducive thereto, subject to applicable laws, licences, registrations, approvals and permissions. Particulars Details 9. To establish, operate, manage and provide food and beverage and allied services in or in connection with hospitals, medical colleges, medical institutions, healthcare facilities, educational institutions and other establishments of the Company, including cafeterias, canteens, food courts, catering facilities, restaurants, cafés, bakeries, confectioneries and other food and beverage establishments, and to undertake the preparation, processing, manufacture, procurement, packaging, distribution, marketing, sale and supply of food, beverages and allied products and services incidental or conducive thereto, subject to applicable laws.